Jillian Dilmore - Baudax BioInc Corp Controller
| BXRX Stock | USD 0.01 0.0009 8.04% |
Insider
Jillian Dilmore is Corp Controller of Baudax BioInc
| Address | 490 Lapp Road, Malvern, PA, United States, 19355 |
| Phone | 484 395 2440 |
| Web | https://www.baudaxbio.com |
Baudax BioInc Management Efficiency
The company has return on total asset (ROA) of (1.1493) % which means that it has lost $1.1493 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (47.0421) %, meaning that it created substantial loss on money invested by shareholders. Baudax BioInc's management efficiency ratios could be used to measure how well Baudax BioInc manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 4.70 in 2024, whereas Return On Tangible Assets are likely to drop (7.03) in 2024. At this time, Baudax BioInc's Intangible Assets are fairly stable compared to the past year. Debt To Assets is likely to rise to 0.67 in 2024, whereas Total Assets are likely to drop slightly above 8.6 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Tomasz George | Virax Biolabs Group | 40 | |
| MD FAAAAI | Palisade Bio | N/A | |
| Waldemar Priebe | Cns Pharmaceuticals | N/A | |
| Jean Lechance | Altamira Therapeutics | N/A | |
| Steen Knudsen | Allarity Therapeutics | 63 | |
| Professor MD | Allarity Therapeutics | 67 | |
| Michael Myers | Quoin Pharmaceuticals Ltd | 62 | |
| Jeffrey Millard | Ensysce Biosciences | 48 | |
| David Hale | Dermata Therapeutics | 75 | |
| MD DrSc | Allarity Therapeutics | 81 | |
| Denise Carter | Quoin Pharmaceuticals Ltd | 55 | |
| Joan Brown | Allarity Therapeutics | 70 | |
| Linda Pestano | Ensysce Biosciences | 54 | |
| Sharon McBrayer | Palisade Bio | N/A | |
| John CPA | Windtree Therapeutics | 60 | |
| Samuel MD | Altamira Therapeutics | 71 | |
| Jason Davis | Virax Biolabs Group | 52 | |
| Claus Pedersen | Allarity Therapeutics | 52 | |
| Tracy Rarick | Windtree Therapeutics | N/A | |
| Diane Esq | Windtree Therapeutics | 55 | |
| Ronald Dundore | Windtree Therapeutics | 69 | |
Management Performance
| Return On Equity | -47.04 | ||||
| Return On Asset | -1.15 |
Baudax BioInc Leadership Team
Elected by the shareholders, the Baudax BioInc's board of directors comprises two types of representatives: Baudax BioInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Baudax. The board's role is to monitor Baudax BioInc's management team and ensure that shareholders' interests are well served. Baudax BioInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Baudax BioInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Natalie McAndrew, Consultant Officer | ||
| Jillian Dilmore, Corp Controller | ||
| Diane Myers, VP Quality | ||
| Chan Yong, Chief Director | ||
| Geraldine Henwood, CEO President | ||
| Mike Choi, Vice Analysis |
Baudax Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Baudax BioInc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -47.04 | ||||
| Return On Asset | -1.15 | ||||
| Operating Margin | (27.60) % | ||||
| Current Valuation | 17.72 M | ||||
| Shares Outstanding | 43.59 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 2.68 % | ||||
| Number Of Shares Shorted | 493.56 K | ||||
| Price To Earning | 0.03 X | ||||
| Price To Book | 0.68 X |
Pair Trading with Baudax BioInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Baudax BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baudax BioInc will appreciate offsetting losses from the drop in the long position's value.Moving against Baudax Stock
| 0.82 | HCWB | HCW Biologics | PairCorr |
| 0.8 | KRYS | Krystal Biotech Financial Report 13th of May 2024 | PairCorr |
| 0.77 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.63 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.62 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
The ability to find closely correlated positions to Baudax BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Baudax BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Baudax BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Baudax BioInc to buy it.
The correlation of Baudax BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Baudax BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Baudax BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Baudax BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Baudax Stock analysis
When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.13) | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.23) | Return On Assets (1.15) | Return On Equity (47.04) |
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.